0001179110-19-003446.txt : 20190306
0001179110-19-003446.hdr.sgml : 20190306
20190306170414
ACCESSION NUMBER: 0001179110-19-003446
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190304
FILED AS OF DATE: 20190306
DATE AS OF CHANGE: 20190306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dorsch Marion
CENTRAL INDEX KEY: 0001690460
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 19663287
MAIL ADDRESS:
STREET 1: BLUEPRINT MEDICINES CORPORATION
STREET 2: 38 SIDNEY STREET, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2019-03-04
0
0001597264
Blueprint Medicines Corp
BPMC
0001690460
Dorsch Marion
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Scientific Officer
Common Stock
2019-03-04
4
M
0
2300
37.11
A
2300
D
Common Stock
2019-03-04
4
S
0
295
87.73
D
2005
D
Common Stock
2019-03-04
4
S
0
498
85.64
D
1507
D
Common Stock
2019-03-04
4
S
0
600
84.72
D
907
D
Common Stock
2019-03-04
4
S
0
800
83.16
D
107
D
Common Stock
2019-03-04
4
S
0
107
82.56
D
0
D
Stock Option (Right to Buy)
37.11
2019-03-04
4
M
0
2300
0
D
2026-11-21
Common Stock
2300
75600
D
Effected pursuant to a trading plan adopted on December 18, 2017 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.57 to $88.04 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.24 to $86.19 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.17 to $85.05 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.63 to $83.58 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.53 to $82.56 per share.
This option was granted on November 21, 2016. This option vested with respect to 25% of the shares underlying the option on November 21, 2017 and vests as to an additional 1/48th of the shares underlying the option each month thereafter.
/s/ Christopher Frankenfield, Attorney-in-Fact
2019-03-06